[Clinical suitability of brain tumor patients for single voxel protein MR spectroscopy].
Usenius
J P
JP
Abteilung für Klinische Radiologie, Universitätsklinik Kuopio, Finnland.
D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000503:physiopathology / Q000601:surgery; D002455:Cell Division / Q000502:physiology*; D002794:Choline / Q000378:metabolism; D003401:Creatine / Q000378:metabolism; D004734:Energy Metabolism / Q000502:physiology*; D006801:Humans; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D014882:Water-Electrolyte Balance / Q000502:physiology*
D007773:Lactates; D001224:Aspartic Acid; D019344:Lactic Acid; C000179:N-acetylaspartate; D003401:Creatine; D002794:Choline
Klinische Eignung von Hirntumorpatienten in der Single-Voxel-Protonen-MR-Spektroskopie.